The neuroprotective effects of Galectin-1 on Parkinson’s Disease via regulation of Nrf2 expression
H.-B. Liu, Q.-Y. Li, X.-D. Zhang, Y. Shi, J.-Y. Li No. 2 Department of Geriatrics, Beijing Geriatric Hospital, Beijing, China. honbin1105@163.com
OBJECTIVE: Parkinson’s disease (PD) is one of the neurodegenerative diseases. Galectin-1 (Gal-1) is expressed in the central nervous system. Our study sought to explore the neuroprotective effect of Gal-1 in 1‑methyl‑4‑phenyl pyridine ion (MPP+)-induced cytotoxicity on SH-SY5Y cells.
MATERIALS AND METHODS: SH-SY5Y cells were cultured in vitro, pretreated with Gal-1, and then exposed to MPP+. Thereafter, the generation of reactive oxygen species (ROS) in SH-SY5Y cells was investigated. The effects of Gal-1 on DNA breakage, cell damage (release of lactate dehydrogenase (LDH)), viability, and apoptosis in SH-SY5Y cells were examined by comet assay, LDH assay, WST-1 assay, and flow cytometry, respectively. Additionally, the regulatory effect of Gal-1 on Nrf2 expression was examined by western blot. Zebrafish embryos were pretreated with Gal-1 and then exposed to MPP+. The locomotor ability of zebrafish larvae was then investigated.
RESULTS: MPP+ induced the production of ROS in cells, which can be alleviated by pretreatment with Gal-1. Gal-1 protected cells from MPP+-induced cytotoxicity by preventing DNA breakage and cell injury. Gal-1 inhibited apoptosis in SH-SY5Y cells. The neuroprotective effect of Gal-1 could be abolished when Nrf2 expression knockdown. Moreover, exposure to MPP+ decreased the locomotor activity of zebrafish, which was attenuated by pretreatment with Gal-1.
CONCLUSIONS: Our study demonstrated that the administration of Gal-1 could protect neurons from cellular stress by preventing apoptosis and eliminating ROS. Moreover, the neuroprotective effect of Gal-1 in neuronal cells could be related to the activation of Nrf2 expression. Therefore, Gal-1 could be a promising strategy for treating PD.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
H.-B. Liu, Q.-Y. Li, X.-D. Zhang, Y. Shi, J.-Y. Li
The neuroprotective effects of Galectin-1 on Parkinson’s Disease via regulation of Nrf2 expression
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 2
Pages: 623-636
DOI: 10.26355/eurrev_202201_27889